Overview

• The model converts stem cells to brain cells with Parkinson's protein structures within weeks.
• It enables high-throughput genetic and drug screening, aiding diagnostics and drug discovery.
• Researchers can now study patient-specific cellular pathologies more efficiently.
• The technology may lead to personalized diagnostic and treatment methods for Parkinson's disease.
• Future work aims to address current limitations, including generating mature neurons.